These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37088463)

  • 1. Quantile Index Biomarkers Based on Single-Cell Expression Data.
    Yi M; Zhan T; Peck AR; Hooke JA; Kovatich AJ; Shriver CD; Hu H; Sun Y; Rui H; Chervoneva I
    Lab Invest; 2023 Aug; 103(8):100158. PubMed ID: 37088463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry data.
    Yi M; Zhan T; Peck AR; Hooke JA; Kovatich AJ; Shriver CD; Hu H; Sun Y; Rui H; Chervoneva I
    BMC Bioinformatics; 2023 Jul; 24(1):298. PubMed ID: 37481512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of spatial tumor heterogeneity in immunohistochemistry staining images.
    Chervoneva I; Peck AR; Yi M; Freydin B; Rui H
    Bioinformatics; 2021 Jun; 37(10):1452-1460. PubMed ID: 33275142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative single-cell analysis of immunofluorescence protein multiplex images illustrates biomarker spatial heterogeneity within breast cancer subtypes.
    Cheung AM; Wang D; Liu K; Hope T; Murray M; Ginty F; Nofech-Mozes S; Martel AL; Yaffe MJ
    Breast Cancer Res; 2021 Dec; 23(1):114. PubMed ID: 34922607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization.
    Annaratone L; Simonetti M; Wernersson E; Marchiò C; Garnerone S; Scalzo MS; Bienko M; Chiarle R; Sapino A; Crosetto N
    Oncotarget; 2017 Mar; 8(12):18680-18698. PubMed ID: 28423635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in quantitative immunohistochemistry and their contribution to breast cancer.
    Yaghoobi V; Martinez-Morilla S; Liu Y; Charette L; Rimm DL; Harigopal M
    Expert Rev Mol Diagn; 2020 May; 20(5):509-522. PubMed ID: 32178550
    [No Abstract]   [Full Text] [Related]  

  • 8. Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.
    Peck AR; Girondo MA; Liu C; Kovatich AJ; Hooke JA; Shriver CD; Hu H; Mitchell EP; Freydin B; Hyslop T; Chervoneva I; Rui H
    Mod Pathol; 2016 Oct; 29(10):1143-54. PubMed ID: 27312066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining fluorescence-based image segmentation and automated microfluidics for ultrafast cell-by-cell assessment of biomarkers for HER2-type breast carcinoma.
    Migliozzi D; Nguyen HT; Gijs MAM
    J Biomed Opt; 2018 Nov; 24(2):1-8. PubMed ID: 30484294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinically feasible diagnostic spectro-histology built on SERS-nanotags for multiplex detection and grading of breast cancer biomarkers.
    Murali VP; Karunakaran V; Murali M; Lekshmi A; Kottarathil S; Deepika S; Saritha VN; Ramya AN; Raghu KG; Sujathan K; Maiti KK
    Biosens Bioelectron; 2023 May; 227():115177. PubMed ID: 36871528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust biomarker discovery through multiplatform multiplex image analysis of breast cancer clinical cohorts.
    Eng J; Bucher E; Hu Z; Sanders M; Chakravarthy B; Gonzalez P; Pietenpol JA; Gibbs SL; Sears RC; Chin K
    bioRxiv; 2023 May; ():. PubMed ID: 36778343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology.
    Paulik R; Micsik T; Kiszler G; Kaszál P; Székely J; Paulik N; Várhalmi E; Prémusz V; Krenács T; Molnár B
    Cytometry A; 2017 Jun; 91(6):595-608. PubMed ID: 28472544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and significantly reduces ambiguous (2+) read-outs.
    Ciftlik AT; Lehr HA; Gijs MA
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5363-8. PubMed ID: 23479638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer.
    Jahangir CA; Page DB; Broeckx G; Gonzalez CA; Burke C; Murphy C; Reis-Filho JS; Ly A; Harms PW; Gupta RR; Vieth M; Hida AI; Kahila M; Kos Z; van Diest PJ; Verbandt S; Thagaard J; Khiroya R; Abduljabbar K; Acosta Haab G; Acs B; Adams S; Almeida JS; Alvarado-Cabrero I; Azmoudeh-Ardalan F; Badve S; Baharun NB; Bellolio ER; Bheemaraju V; Blenman KR; Botinelly Mendonça Fujimoto L; Burgues O; Chardas A; Cheang MCU; Ciompi F; Cooper LA; Coosemans A; Corredor G; Dantas Portela FL; Deman F; Demaria S; Dudgeon SN; Elghazawy M; Fernandez-Martín C; Fineberg S; Fox SB; Giltnane JM; Gnjatic S; Gonzalez-Ericsson PI; Grigoriadis A; Halama N; Hanna MG; Harbhajanka A; Hart SN; Hartman J; Hewitt S; Horlings HM; Husain Z; Irshad S; Janssen EA; Kataoka TR; Kawaguchi K; Khramtsov AI; Kiraz U; Kirtani P; Kodach LL; Korski K; Akturk G; Scott E; Kovács A; Laenkholm AV; Lang-Schwarz C; Larsimont D; Lennerz JK; Lerousseau M; Li X; Madabhushi A; Maley SK; Manur Narasimhamurthy V; Marks DK; McDonald ES; Mehrotra R; Michiels S; Kharidehal D; Minhas FUAA; Mittal S; Moore DA; Mushtaq S; Nighat H; Papathomas T; Penault-Llorca F; Perera RD; Pinard CJ; Pinto-Cardenas JC; Pruneri G; Pusztai L; Rajpoot NM; Rapoport BL; Rau TT; Ribeiro JM; Rimm D; Vincent-Salomon A; Saltz J; Sayed S; Hytopoulos E; Mahon S; Siziopikou KP; Sotiriou C; Stenzinger A; Sughayer MA; Sur D; Symmans F; Tanaka S; Taxter T; Tejpar S; Teuwen J; Thompson EA; Tramm T; Tran WT; van der Laak J; Verghese GE; Viale G; Wahab N; Walter T; Waumans Y; Wen HY; Yang W; Yuan Y; Bartlett J; Loibl S; Denkert C; Savas P; Loi S; Specht Stovgaard E; Salgado R; Gallagher WM; Rahman A
    J Pathol; 2024 Mar; 262(3):271-288. PubMed ID: 38230434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer.
    Shamai G; Binenbaum Y; Slossberg R; Duek I; Gil Z; Kimmel R
    JAMA Netw Open; 2019 Jul; 2(7):e197700. PubMed ID: 31348505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.
    Zafrakas M; Petschke B; Donner A; Fritzsche F; Kristiansen G; Knüchel R; Dahl E
    BMC Cancer; 2006 Apr; 6():88. PubMed ID: 16603086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multiplex immunoprofiling approach for detecting the co-localization of breast cancer biomarkers using a combination of Alexafluor - Quantum dot conjugates and a panel of chromogenic dyes.
    Sharaf SS; Lekshmi A; S A; K G A; Jyothi S P A; Chandrasekharan A; Somanathan T; Santhosh Kumar TR; K S
    Pathol Res Pract; 2024 Jan; 253():155033. PubMed ID: 38134837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.
    Shubbar E; Kovács A; Hajizadeh S; Parris TZ; Nemes S; Gunnarsdóttir K; Einbeigi Z; Karlsson P; Helou K
    BMC Cancer; 2013 Jan; 13():1. PubMed ID: 23282137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automatic tumor-stroma separation in fluorescence TMAs enables the quantitative high-throughput analysis of multiple cancer biomarkers.
    Lahrmann B; Halama N; Sinn HP; Schirmacher P; Jaeger D; Grabe N
    PLoS One; 2011; 6(12):e28048. PubMed ID: 22164226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinoma.
    Ronchi A; Pagliuca F; Zito Marino F; Accardo M; Cozzolino I; Franco R
    Semin Cancer Biol; 2021 Jul; 72():114-122. PubMed ID: 32165319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.